MPM BioVentures 2014, L.P., 10% Owner at Entrada Therapeutics, Inc. (TRDA), sold 62,714 shares at $7.34 ($462K) on 2026-08-24, disclosed to the SEC on 2026-08-26.
Open-market sale of $462k TRDA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.34 | 21,623 | $159K | 34.4% |
| 2 | $7.54 | 26,522 | $200K | 43.3% |
| 3 | $7.06 | 14,569 | $103K | 22.3% |
| Total | $7.36 avg | 62,714 | $462K | 100% |
| Filing → |
| TRDA | SELL | 2026-08-31 | $616K | — | Filing → |
| HOWL | SELL | 2025-11-12 | $438K | — | Filing → |
| ITOS | SELL | 2021-10-18 | $939K | — | Filing → |